Long‐Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS‐TIMI 54 Trial

Long‐Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS‐TIMI 54 Trial

Background Coronary stent type and risk of stent thrombosis remain important factors affecting recommended duration of dual antiplatelet therapy. We investigated the efficacy and safety of long‐term ticagrelor in patients with prior coronary stenting enrolled in the PEGASUS‐TIMI 54 (Prevention of Ca...

Full description

Bibliographic Details
Main Authors: Brian A. Bergmark, Deepak L. Bhatt, P. Gabriel Steg, Andrzej Budaj, Robert F. Storey, Yared Gurmu, Julia F. Kuder, KyungAh Im, Giulia Magnani, Ton Oude Ophuis, Christian Hamm, Jindřich Špinar, Robert G. Kiss, Frans J. Van de Werf, Gilles Montalescot, Per Johanson, Eugene Braunwald, Marc S. Sabatine, Marc P. Bonaca
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
acute coronary syndrome
antiplatelet therapy
P2Y12 inhibitor
PCI
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.020446

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.120.020446

Similar Items